<DOC>
	<DOCNO>NCT00231556</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness two dos topiramate monotherapy treatment pediatric adult patient newly diagnose recurrent epilepsy .</brief_summary>
	<brief_title>A Study Safety Efficacy Two Doses Topiramate Monotherapy Treatment Newly Diagnosed Recurrent Epilepsy</brief_title>
	<detailed_description>Topiramate approve treat epilepsy combination epilepsy drug , approve treat epilepsy sole treatment recently diagnose epilepsy characterize partial-onset seizure . This randomized , double-blind , parallel-group , multicenter study compare safety effectiveness two dos topiramate monotherapy pediatric adult patient newly diagnose ( within 3 month ) recurrent epilepsy ( partial-onset primary generalize tonic-clonic ) . The study consist 4 phase : Baseline ( assessment seizure frequency eligibility ) , Open-Treatment ( patient receive 25 milligram [ mg ] /day topiramate 7 day ) , Core Double-Blind Phase ( patient randomize receive either assign dose topiramate 50mg/day 400mg/day , maximum tolerate dose , remain , possible , dose duration double-blind phase ; continue receive medication experience first seizure 6 month last patient enrol ) , Long-Term Extension Phase ( patient continue receive medication maximum tolerate dose , may adjust accord individual tolerability effectiveness , either patient withdraws sponsor terminates study ) . The study hypothesis topiramate effective treatment newly diagnose recurrent epilepsy dose-dependent manner . Topiramate tablet ( 25 milligram [ mg ] ) daily mouth once-daily regimen 7-day Open-Treatment Phase ; topiramate twice daily total 50mg/day 400mg/day Double-Blind Phase .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Epilepsy , Tonic-Clonic</mesh_term>
	<mesh_term>Epilepsy , Generalized</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Weigh &gt; =25 kilograms Diagnosis epilepsy within 3 month prior study entry recurrence epilepsy anitepileptic drug No two document seizure threemonth retrospective baseline phase may experience seizure prior threemonth , retrospective baseline phase Patients partialonset seizure , without secondarily generalize component , generalized seizure , include tonicclonic ( grand mal ) , tonic , clonic , juvenile myoclonic epilepsy ( impulsive petit mal ) myoclonic epilepsy Receiving either concomitant antiepileptic drug ( AED ) one standard AED . Patients epilepsy Patients absence ( petit mal ) atypical absence seizure , epilepsia paritlis continuum , cluster pattern serial seizure Patients progressive neurological degenerative disorder Patients significant history unstable medical disease Patients drug allergy hypersensitivity carbonic anhydrase inhibitor sulfa drug Patients history alcohol drug abuse within past one year Patients history suicide attempt within past one year .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Seizures</keyword>
	<keyword>Parital Epilepsies</keyword>
	<keyword>Generalized Epilepsy</keyword>
	<keyword>Tonic-Clonic Epilepsy</keyword>
	<keyword>Topiramate</keyword>
</DOC>